AMRX Amneal Pharmaceuticals Inc - Class A

  1. Stocks
  2. Healthcare
  3. NASDAQ: AMRX

Price (delayed)

$20.44

Market cap

$6.53B

P/E Ratio

40.88

Dividend/share

N/A

EPS

$0.5

Enterprise value

$9.18B

?
Relative Growth: Rel. Growth: 80
Relative Strength: Rel. Strength: 92
Relative Valuation: Rel. Valuation: 72
Relative Profitability: Rel. Profitability: 55
Highlights
Amneal Pharmaceuticals's equity has surged by 173% QoQ and by 129% YoY
The P/E is 74% below the last 4 quarters average of 155.4
AMRX's quick ratio has soared by 64% YoY but it is down by 10% from the previous quarter
AMRX's debt is up by 8% year-on-year and by 3.5% since the previous quarter
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.amneal.com

Key stats

What are the main financial stats of AMRX

AMRX stock price

How has the Amneal Pharmaceuticals stock price performed over time
Intraday
-4.97%
1 week
-2.76%
1 month
0.69%
1 year
88.91%
YTD
62.22%
QTD
1.49%

Financial performance

How have Amneal Pharmaceuticals's revenue and profit performed over time
Revenue
$3.12B
Gross profit
$1.23B
Operating income
$453.92M
Net income
$157.36M
Gross margin
39.3%
Net margin
5%
The company's net income rose by 29% QoQ
AMRX's net margin is up by 25% since the previous quarter
The company's operating income rose by 21% YoY and by 4.2% QoQ
The company's gross profit rose by 14% YoY and by 4.1% QoQ

Price vs fundamentals

How does AMRX's price correlate with its fundamentals

Growth

What is Amneal Pharmaceuticals's growth rate over time

Valuation

What is Amneal Pharmaceuticals stock price valuation
AMRX P/E details
P/E
40.88
P/B
197.46
P/S
2.09
EV/EBIT
24.77
EV/EBITDA
16.25
EV/Sales
2.95
The P/E is 74% below the last 4 quarters average of 155.4
AMRX's EPS is up by 28% since the previous quarter
Amneal Pharmaceuticals's equity has surged by 173% QoQ and by 129% YoY
The price to sales (P/S) is 199% higher than the 5-year quarterly average of 0.7 and 49% higher than the last 4 quarters average of 1.4
AMRX's revenue is up by 9% year-on-year and by 2.4% since the previous quarter

Efficiency

How efficient is Amneal Pharmaceuticals business performance
The company's return on assets rose by 26% QoQ
AMRX's ROS is up by 17% year-on-year
AMRX's ROIC is up by 10% YoY

Dividends

What is AMRX's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for AMRX.

Financial health

How did Amneal Pharmaceuticals financials performed over time
AMRX's quick ratio has soared by 64% YoY but it is down by 10% from the previous quarter
The company's current ratio has surged by 54% YoY but it fell by 11% QoQ
Amneal Pharmaceuticals's equity has surged by 173% QoQ and by 129% YoY
AMRX's debt is up by 8% year-on-year and by 3.5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.